captopril has been researched along with Adenocarcinoma, Basal Cell in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batsalova, T; Dzhambazov, B; Klaczkowska, D; Kostova, Z; Teneva, I | 1 |
| Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW | 1 |
| Amore, C; Cugino, D; Cutrone, A; de Gaetano, G; Di Santo, A; Donati, MB; Iacoviello, L; Lorenzet, R; Napoleone, E | 1 |
| Morris, TM; Parsons, SL; Rowlands, BJ; Watson, SA; Williams, RN | 1 |
| Bussink, M; Menheere, PP; van der Kuy, PH; van Mook, WN; van Onzenoort, HA | 1 |
| Hiwada, K; Kokubu, T; Takada, Y | 1 |
| Baskaran, K; Molteni, A; Reddy, MK | 1 |
| Bargout, R; Bifero, A; Filippatos, G; Flynn, K; Gidea, C; Ibarra-Sunga, O; Papp, M; Uhal, BD | 1 |
| Williams, NE | 1 |
| Bargout, R; Dincer, E; Filippatos, G; Ibarra-Sunga, O; Jankov, A; Komodromos, T; Uhal, BD; Wang, R | 1 |
| Barthel, JS; Coppola, D; Hiotis, S; Karl, RC; Kocab, MA | 1 |
11 other study(ies) available for captopril and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
Influence of captopril on the cellular uptake and toxic potential of microcystin-LR in non-hepatic adhesive cell lines.
Topics: Adenocarcinoma; Amnion; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cell Adhesion; Cell Line; Drug Interactions; Humans; Liver Neoplasms; Lung Neoplasms; Marine Toxins; Membrane Transport Proteins; Microcystins | 2016 |
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
Inhibition of the renin-angiotensin system downregulates tissue factor and vascular endothelial growth factor in human breast carcinoma cells.
Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Breast Neoplasms; Captopril; Cell Line, Tumor; Down-Regulation; Enalapril; Female; Humans; MCF-7 Cells; Neovascularization, Pathologic; Renin-Angiotensin System; Thromboplastin; Vascular Endothelial Growth Factor A | 2012 |
Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dose-Response Relationship, Drug; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Nude; Neoplasm Transplantation; Stomach Neoplasms; Tumor Cells, Cultured | 2005 |
The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels.
Topics: Adenocarcinoma; Administration, Sublingual; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalaprilat; Female; Humans; Injections, Intravenous; Intestinal Polyposis; Pancreatic Neoplasms; Parenteral Nutrition | 2006 |
Characterization and immunohistologic demonstration of angiotensin-converting enzyme in human renal cell carcinoma.
Topics: Adenocarcinoma; Captopril; Fluorescent Antibody Technique; Humans; Immunodiffusion; Immunoenzyme Techniques; Isoenzymes; Kidney; Kidney Neoplasms; Male; Middle Aged; Peptidyl-Dipeptidase A | 1983 |
Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells.
Topics: Adenocarcinoma; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Division; Cricetinae; Gene Expression Regulation, Neoplastic; Indoles; Mesocricetus; Mitosis; Pancreatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Apoptosis; Captopril; Caspase 1; Caspase 3; Caspases; DNA Fragmentation; Epithelial Cells; fas Receptor; Humans; Lung; Lung Neoplasms; Mice; Models, Biological; Pulmonary Fibrosis; Tumor Cells, Cultured | 1998 |
Profound bradycardia and hypotension following spinal anaesthesia in a patient receiving an ACE inhibitor: an important 'drug' interaction?
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anesthesia, Spinal; Angiotensin-Converting Enzyme Inhibitors; Bradycardia; Captopril; Drug Interactions; Humans; Hypotension; Male; Prostatic Neoplasms; Transurethral Resection of Prostate | 1999 |
Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cysteine Proteinase Inhibitors; Cytotoxins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Humans; In Vitro Techniques; Lung Neoplasms; Male; Pulmonary Alveoli; Rats; Rats, Wistar; Renin-Angiotensin System; Tumor Cells, Cultured | 2000 |
Captopril-associated cholestasis complicating the management of pancreatic cancer.
Topics: Adenocarcinoma; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cholestasis; Comorbidity; Coronary Disease; Drainage; Endoscopy; Humans; Male; Pancreatic Neoplasms; Treatment Outcome | 2000 |